Table 1.

Demographic characteristics of records included in the systematic review.

StudyStudy DesignSSc CriteriaSample Size, n = SSc/IPAH/HCSSc-PAH/SSc-noPAHRight Heart Catheterization Diagnosis of SSc-PAH (mPAP, PCWP, PVR) and Guidelines Followed by the AuthorsNVC Assessment
Sulli, 2012, Italy30Longitudinal(29a)38/0/04*/34mPAP > 25 mmHg. Other guidelines not statedVideocapillaroscopy, 200× magnification
Avouac, 2017, France31Longitudinal(18)140/0/08*/132mPAP ≥ 25 mmHg, PCWP ≤ 15 mmHg, 2009 ESC/ERS guidelines21Videocapillaroscopy, 200× magnification
Hofstee, 2009, Netherlands32Cross-sectional(29a)40/20/2121/19mPAP > 25 mmHg, 2004 ESC guidelines20Computer-based panorama mosaic videocapillaroscopy
Riccieri, 2013, Italy33Cross-sectional(29a)24/0/012/12mPAP > 25 mmHg, 2009 ACCF/AHA guidelines22Videocapillaroscopy, 200× magnification
Corrado, 2017, Italy34Cross-sectional(18)39/21/2519/20mPAP ≥ 25 mmHg, PCWP ≤ 15 mmHg, PVR > 3 WU, 2015 ESC/ERS guidelines9Videocapillaroscopy, 200× magnification
  • * Occurrence of incident SSc-PAH during followup period. ACCF: American College of Cardiology Foundation; AHA: American Heart Association; ERS: European Respiratory Society; ESC: European Society of Cardiology; HC: healthy controls; IPAH: idiopathic pulmonary arterial hypertension; mPAP: mean pulmonary arterial pressure; NVC: nailfold videocapillaroscopy; PCWP: pulmonary capillary wedge pressure; PVR: pulmonary vascular resistance; SSc: systemic sclerosis; SSc-noPAH: systemic sclerosis without PAH; SSc-PAH: systemic sclerosis–related PAH; WU: Wood units.